The trial posting for A Phase IIb, Multi-national, doublie-blind, randomized, placebo-controlled study to evaluate the safety, tolerability, and efficacy of CK-2017357 in patients with Amyotrophic Lateral Sclerosis (ALS) is not listed as active in clinicaltrials.partners.org database. The trial may have stopped recruiting.